US Patent Issued to THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE on July 7 for "Methods and kits for the detection of SARS-CoV-2" (Arizona Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,200, issued on July 7, was assigned to THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (Phoenix).

"Methods and kits for the detection of SARS-CoV-2" was invented by David Engelthaler (Flagstaff, Ariz.), Jolene Bowers (Flagstaff, Ariz.) and James Schupp (Flagstaff, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, kits, and oligonucleotides used in the detection of the coronavirus strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are disclosed. In some aspects, the oligonucleotides are primers or probes used in the described methods or kits. The oligonucleotide consists of 40 or less nucleotides and has a nucleotide seque...